Photronics, Inc. (PLAB)
NASDAQInformation TechnologySemiconductorsSnapshot 2026-09-09
$29.10-0.89%
Close 2026-09-09 · 1-day change
NASDAQInformation TechnologySemiconductorsSnapshot 2026-09-09
Broken: Primary pillar broken — Maintain revenue near $210 million per quarter: Q3 rev $216.0M vs $209.0M target.
Photronics keeps profit margins near 19%. Earnings per share rose from $0.15 to $0.54 in a year. Revenue is stable near $210 million despite market challenges. The company controls costs well and improves efficiency.
Revenue fell 0.5% year-over-year in the latest quarter. Earnings per share missed estimates by 20%. The recent sharp stock selloff shows investor doubts. Market headwinds may pressure growth and margins.
The price is about 56% below our fair value near $66. Analysts expect about 3% revenue growth. The market prices in weak near-term growth and some risk, which matches recent results.
Breaks if: EPS falls below $0.39 next quarter
Drive earnings per share growth by improving operational performance and managing costs effectively.
Stated as a priority in 3 of last 3 quarters. Non-GAAP diluted EPS declined from $0.61 in 2026-Q1 to $0.42 in 2026-Q2, then improved to $0.50 in 2026-Q3. The EPS trajectory shows volatility with partial recovery, indicating limited progress toward consistent EPS growth.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a durable compounder with a focus on the high-end photomask market. The current thesis state is intact, supported by recent earnings beats, but there are mixed signals in revenue growth and operating margins.
The market currently prices PLAB as cheap compared to its peers, with an expectations gap indicating that some negative sentiment is already reflected in its valuation. There is low fragility in the current market regime, suggesting stability in its pricing.
Fundamentals show a mixed trajectory, with recent earnings indicating some recovery in revenue but ongoing challenges in achieving operating margin targets. Management's focus on strengthening its market position is evident, but volatility remains a concern.
The long-term thesis hinges on management's ability to maintain revenue growth and improve operating margins. Additionally, external factors such as Federal Reserve rate cuts and performance from sector leaders like NVDA and TSM could significantly influence PLAB's trajectory.
The most important moves since the prior daily snapshot.
Yes, our read has weakened. The latest earnings beat is a positive sign. However, a sharp drop in the stock may be repricing the thesis. This suggests the market is reassessing the reasons to own PLAB. The company is still strengthening its position in the high-end photomask market.
as of 2026-09-09
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
“Non-GAAP diluted EPS was $0.50 in Q3 2026.”
“Non-GAAP diluted EPS was $0.42 in Q2 2026.”
“Non-GAAP diluted EPS was $0.61 in Q1 2026.”
Breaks if: operating margin falls below 18%
Focus on improving operating margins with targets set between 18% and 24% for upcoming quarters.
Stated as a priority in 3 of last 3 quarters. Operating margin declined from 24.4% in 2026-Q1 to 20.1% in 2026-Q2, with guidance for 18%-20% in 2026-Q3. The trajectory shows a downward trend, indicating limited progress toward higher margin targets.
“Operating margin to be between 18% and 20% for Q3 2026.”
“Operating margin was 20.1% in Q2 2026.”
“Operating margin was 24.4% in Q1 2026.”
Breaks if: quarterly revenue falls below $209 million
Sustain and grow overall revenue through market recovery and product demand, targeting sequential and year-over-year increases.
Stated as a priority in 3 of last 3 quarters. Revenue peaked at $225.1M in 2026-Q1, declined to $209.9M in 2026-Q2, then partially recovered to $216.0M in 2026-Q3. The trajectory shows some volatility with limited progress toward consistent growth.
“Revenue was $216.0 million, an increase of 2.7% year-over-year and 2.9% sequentially.”
“Revenue was $209.9 million, down 0.5% year-over-year and down 6.7% sequentially.”
“Revenue was $225.1 million, up 6.1% year-over-year and up 4.3% sequentially.”
In the next 1 to 3 years, PLAB's performance will depend on both internal execution and external market conditions. Not investment advice.